A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!

Comment

H H Dubben et al. Int J Radiat Oncol Biol Phys. 2001.

. 2001 Oct 1;51(2):563.

doi: 10.1016/s0360-3016(01)01661-3.

No abstract available

Comment on

Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment ... now!
Bentzen SM, Vaeth M, Pedersen DE, Overgaard J. Bentzen SM, et al. Int J Radiat Oncol Biol Phys. 1995 Jul 30;32(5):1531-4. doi: 10.1016/0360-3016(95)00262-W. Int J Radiat Oncol Biol Phys. 1995. PMID: 7635798 Review. No abstract available.
Transmutability of dose and time. Commentary on the first report of RTOG 90003 (K. K. FU et al.).
Withers HR, Peters LJ. Withers HR, et al. Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):1-2. doi: 10.1016/s0360-3016(00)00644-1. Int J Radiat Oncol Biol Phys. 2000. PMID: 10924964 No abstract available.
Confirmation of improved local-regional control with altered fractionation in head and neck cancer.
Fowler JF, Harari PM. Fowler JF, et al. Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):3-6. doi: 10.1016/s0360-3016(00)00643-x. Int J Radiat Oncol Biol Phys. 2000. PMID: 10924965 No abstract available.
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL, Garden AS, Ridge JA, Cooper JS, Ang KK. Fu KK, et al. Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):7-16. doi: 10.1016/s0360-3016(00)00663-5. Int J Radiat Oncol Biol Phys. 2000. PMID: 10924966 Clinical Trial.